Compounds > haloperidol

haloperidol and curcumin

haloperidol has been researched along with curcumin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Bishnoi, M; Chopra, K; Kulkarni, SK1
Bishnoi, M; Chopra, K; Kulkarni, SK; Rongzhu, L1
Daya, R; Heffernan, S; Mishra, RK; Sookram, C; Tan, M1
Chen, L; Feng, H; Huang, D; Khan, H; Ni, Z; Niu, Y; Shi, G; Wu, X; Xing, Y1

Other Studies

7 other study(ies) available for haloperidol and curcumin

ArticleYear
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
    Chemistry & biology, 2015, Jul-23, Volume: 22, Issue:7

    Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic

2015
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Pharmacology, biochemistry, and behavior, 2008, Volume: 88, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Anti-Dyskinesia Agents; Antipsychotic Agents; Behavior, Animal; Body Weight; Brain Chemistry; Catalase; Curcuma; Curcumin; Dyskinesia, Drug-Induced; Glutathione; Haloperidol; Lipid Peroxidation; Male; Motor Activity; Nerve Tissue Proteins; Neurotransmitter Agents; Rats; Rats, Wistar; Stereotyped Behavior; Sulfhydryl Compounds; Superoxide Dismutase

2008
Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence.
    Neurotoxicity research, 2011, Volume: 20, Issue:3

    Topics: Alkaloids; Analysis of Variance; Animals; Apoptosis; Behavior, Animal; Benzodioxoles; Caspase 3; Colorimetry; Curcumin; Cytokines; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Haloperidol; Inflammation; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotransmitter Agents; Piperidines; Polyunsaturated Alkamides; Rats; Rats, Wistar; Statistics as Topic; Thiobarbituric Acid Reactive Substances

2011
Curcumin prevents haloperidol-induced development of abnormal oro-facial movements: possible implications of Bcl-XL in its mechanism of action.
    Synapse (New York, N.Y.), 2011, Volume: 65, Issue:8

    Topics: Animals; Antipsychotic Agents; bcl-X Protein; Curcumin; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Face; Haloperidol; Male; Mouth; Rats; Rats, Sprague-Dawley

2011
Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 91

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Curcumin; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Haloperidol; Humans; Liver Neoplasms; Mice, Nude; RNA, Long Noncoding; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2021